- Home
- App Analytics
- PDMed
- PDMed Vs. Manual of Clinical Oncology
PDMed vs Manual of Clinical Oncology Usage & Stats
PDMed is an atmosphere which let specialists to share their medical experiences about oncology and nephrology patients and medications.
- Apple App Store
- Free
- Medical
Store Rank
- -
** The Essential Resource for the Care of Oncology Patients **
ABOUT MANUAL OF CLINICAL ONCOLOGY
Manual of Clinical Oncology is a practical guide that provides concise information needed in the management of cancer. This popular resource presents basic principles along with diagnosis and treatment options to aid in the decision-making process. Common complications experienced in therapy are covered and make this powerful app a must-have during rounds or at the bedside.
FEATURES
• Coverage of specific malignancies including solid tumors and hematopoiesis
• Recommendations for a variety of complications seen in therapy
• Detailed figures and tables
• Helpful appendixes including tumor identifiers, chemo regimens, and more
• Links to related information found in chapter outlines
• A Cancer Survival Guide for Women – written by a patient
• PubMed reference links for additional reading
• Highlight and make custom notes within entries
• Full Text Search to locate information quickly
• “Favorites” for bookmarking important entries
Editors: Dennis A. Casciato, MD; Mary C. Territo, MD
Publisher: Lippincott Williams & Wilkins
Powered by: Unbound Medicine
Unbound Privacy Policy: www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
- Apple App Store
- Free
- Medical
Store Rank
- -
PDMed vs. Manual of Clinical Oncology ranking comparison
Compare PDMed ranking trend in the past 28 days vs. Manual of Clinical Oncology
Rank
No Data Available
PDMed vs. Manual of Clinical Oncology ranking by country comparison
Compare PDMed ranking trend in the past 28 days vs. Manual of Clinical Oncology
No Data to Display
Compare to any site with our free trial
PDMed VS.
Manual of Clinical Oncology
December 14, 2024